<?xml version="1.0" encoding="UTF-8"?>
<p id="p0170">Furthermore, the crystal structure of furin allowed the targeted modelling of non-peptidic inhibitors, such as streptamine-based compounds. Upon addition of guanidine residues, streptamine derivatives mimic the cationic furin cleavage site and inhibit its enzymatic activity 
 <italic>in vitro</italic> in the nanomolar range 
 <xref rid="b0250" ref-type="bibr">[50]</xref>. Notably, a 2,5-dideoxystreptamine-based small molecule inhibitor was found to interact with furin showing an unusual binding mode, different from a peptide-based substrate, which inhibits furin with 
 <italic>K</italic>
 <sub>i</sub> = 46 nM. In particular, one molecule of inhibitor anchors at the S4 pocket of the enzyme, directly interfering with the conformation and function of the catalytic triad, while a second molecule shows weaker binding and interacts with a distant, less conserved region of furin 
 <xref rid="b0255" ref-type="bibr">[51]</xref>.
</p>
